US Patent Issued to SPH BIOTHERAPEUTICS (SHANGHAI) Ltd. on July 7 for "Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,145, issued on July 7, was assigned to SPH BIOTHERAPEUTICS (SHANGHAI) Ltd. (Shanghai).

"Vector genetically engineered with chimeric antigen receptor and against two or more targets and application thereof" was invented by Benshang Li (Shanghai), Tianyi Wang (Shanghai), Xinyu Wan (Shanghai) and Xiaomin Yang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a vector genetically engineered with a chimeric antigen receptor and against two or more targets for combined treatment of disease such as human tumors, a related immune cell and application thereof. The vector genetically engineered with a chimeric antigen receptor and the relat...